IPP Bureau
BMSF names diversity in clinical trials training program after Robert A Winn
By IPP Bureau - April 11, 2022
The groundbreaking, uniquely robust Robert A. Winn Diversity in Clinical Trials Award Program is on track to train more than 500 individuals from diverse backgrounds by 2027
Global pharma back Turn Biotechnologies to advance its cell rejuvenation program
By IPP Bureau - April 11, 2022
Daewoong Pharmaceutical, HanAll Biopharma join Astellas Venture Management and other VCs in oversubscribed funding round to accelerate Turn Bio's preclinical advances in multiple therapeutic areas
Lonza signs manufacturing deal with Asher Biotherapeutics
By IPP Bureau - April 11, 2022
Under the manufacturing agreement, Lonza will provide drug substance for Asher Bio's cis-targeted IL-2 fusion protein
Amyris commissions industry-leading fermentation plant
By IPP Bureau - April 11, 2022
The site consists of five fermentation "mini-factories" capable of concurrently producing our more than 13 currently scaled and future bio-fermented products
Moderna kickstarts Phase 1/2 study for influenza vaccine candidate
By IPP Bureau - April 11, 2022
Both mRNA-1020 and mRNA-1030 target hemagglutinin and neuraminidase antigens, two major influenza surface glycoproteins that are essential across the viral life cycle
Venkaiah Naidu inaugurates India’s first ‘integrated diagnostics’ facility
By IPP Bureau - April 11, 2022
Mahajan Imaging, which currently has 10 high-end medical diagnostic centres in Delhi-NCR and Jaipur, has ventured into a new field called Integrated Diagnostics
AstraZeneca Chennai centre repositioned as Global Innovation and Technology Centre
By IPP Bureau - April 10, 2022
With close to 2,800 highly skilled employees, GITC is now one of the largest technology centres across the Life Sciences industry in the country
New research on drug-induced gene signatures for colorectal cancer patients
By IPP Bureau - April 10, 2022
Data to be presented at the 2022 AACR annual meeting highlights the unique nature of post-chemotherapy derived gene expression signatures in stratifying patient outcomes
Innovative therapy that ‘tricks’ and destroys cancer cells advance to clinical trial
By IPP Bureau - April 10, 2022
Results from pre-clinical research show iron-like compound hold promise for treating patients with glioblastoma, an aggressive brain cancer
LivaNova initiates targeted commercial launch of Essenz patient monitor
By IPP Bureau - April 10, 2022
An intuitive monitor featuring a patient-tailored approach is now in clinical use in select centres in U.S. and Europe
Data indicates homeopathy effective in management of long Covid
By IPP Bureau - April 10, 2022
Dr. Kalyan Banerjee's Clinic developed a homeopathy prophylaxis protocol for the prevention of Covid-19 as soon as the pandemic began
India Pharmaceutical Market reports revenue decline in March 2022
By IPP Bureau - April 10, 2022
Ind-Ra expects FY22 IPM to have witnessed 15% YoY sales growth, higher than the 8%-10% observed over the past five years, aided by the base effect
Masina hospital launches a tobacco cessation clinic
By IPP Bureau - April 10, 2022
The hospital is committed to adding to specialised practices in the healthcare space with its pioneering effort to promote oral health awareness and tobacco addiction prevention
Ministry of Ayush to organise two-day convention on World Homeopathy day
By IPP Bureau - April 09, 2022
World Homoeopathy Day is observed to commemorate the birth anniversary of the founder of Homoeopathy, Dr. Christian Fredrich Samuel Hahnemann to mark his 267th birth anniversary
Knowledge Centre for Pharmaceutical Continuous Manufacturing
By IPP Bureau - April 08, 2022
Although PCM has advanced substantially in recent years, most of the valuable technical information resides with private companies and academic publications across multiple platforms
